Patient Guide: Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 205 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04380636
Status: ACTIVE_NOT_RECRUITING
Condition: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Phase: PHASE3

Where You Can Participate

This study is available at 205 locations across the country.

Top locations include:
  • • Mobile, Alabama
  • • Jonesboro, Arkansas
  • • Fullerton, California
  • • And 202 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012) - Join Clinical Trial NCTNCT04380636

How to Join This Clinical Trial - NCTNCT04380636

Learn how to participate in this PHASE3 trial studying an investigational therapy for Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Lung Neoplasms, Carcinoma, Non-Small-Cell Lung
Treatment Being Tested
Investigational treatment
Study Phase
PHASE3 - Large-scale efficacy study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT04380636 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 205 locations. Find a study site near you:

Clinical Research Site

Mobile, Alabama 36604 - United States

Status: Contact for availability

Clinical Research Site

Jonesboro, Arkansas 72401 - United States

Status: Contact for availability

Clinical Research Site

Fullerton, California 92835 - United States

Status: Contact for availability

Clinical Research Site

Long Beach, California 90806 - United States

Status: Contact for availability

Clinical Research Site

Los Angeles, California 90404 - United States

Status: Contact for availability

Clinical Research Site

Santa Rosa, California 95403 - United States

Status: Contact for availability

Clinical Research Site

Torrance, California 90505 - United States

Status: Contact for availability

Clinical Research Site

Hollywood, Florida 33021 - United States

Status: Contact for availability

Clinical Research Site

Miami, Florida 33125 - United States

Status: Contact for availability

Clinical Research Site

Orange City, Florida 32763 - United States

Status: Contact for availability

And 195 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE3 clinical trial for Lung Neoplasms, Carcinoma, Non-Small-Cell Lung:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships